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Both blood- and milk-based biomarkers have been analysed for decades in research settings, although often only in one herd,
and without focus on the variation in the biomarkers that are specifically related to herd or diet. Biomarkers can be used to
detect physiological imbalance and disease risk and may have a role in precision livestock farming (PLF). For use in PLF, it is
important to quantify normal variation in specific biomarkers and the source of this variation. The objective of this study was to
estimate the between- and within-herd variation in a number of blood metabolites (β-hydroxybutyrate (BHB), non-esterified fatty
acids, glucose and serum IGF-1), milk metabolites (free glucose, glucose-6-phosphate, urea, isocitrate, BHB and uric acid), milk
enzymes (lactate dehydrogenase and N-acetyl-β-D-glucosaminidase (NAGase)) and composite indicators for metabolic imbalances
(Physiological Imbalance-index and energy balance), to help facilitate their adoption within PLF. Blood and milk were sampled
from 234 Holstein dairy cows from 6 experimental herds, each in a different European country, and offered a total of 10 different
diets. Blood was sampled on 2 occasions at approximately 14 days-in-milk (DIM) and 35 DIM. Milk samples were collected twice
weekly (in total 2750 samples) from DIM 1 to 50. Multilevel random regression models were used to estimate the variance
components and to calculate the intraclass correlations (ICCs). The ICCs for the milk metabolites, when adjusted for parity and
DIM at sampling, demonstrated that between 12% (glucose-6-phosphate) and 46% (urea) of the variation in the metabolites’
levels could be associated with the herd-diet combination. Intraclass Correlations related to the herd-diet combination were
generally higher for blood metabolites, from 17% (cholesterol) to approximately 46% (BHB and urea). The high ICCs for urea
suggest that this biomarker can be used for monitoring on herd level. The low variance within cow for NAGase indicates that few
samples would be needed to describe the status and potentially a general reference value could be used. The low ICC for most of
the biomarkers and larger within cow variation emphasises that multiple samples would be needed - most likely on the individual
cows - for making the biomarkers useful for monitoring. The majority of biomarkers were influenced by parity and DIM which
indicate that these should be accounted for if the biomarker should be used for monitoring.
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Implications
We quantified normal variation in blood- and milk-based
biomarkers of health and performance among cows housed
in very different feeding and housing conditions. Some bio-
markers like urea were strongly affected by herd factors,
which make them very useful for herd-level monitoring.
Some biomarkers like N-acetyl-β-D-glucosaminidase were
very uniform from day to day at cow level, which make it pos-
sible to monitor health and performance with few samples
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and sometimes to use general reference values. Most bio-
markers were substantively affected by factors like parity
and stage of lactation, which demonstrates that these factors
must be accounted for in monitoring programmes.
Introduction
Modern dairy farming faces many challenges, including the
need to optimise production efficiency, while at the same
time maintaining the physiological balance, health and fer-
tility of the cows. High-yielding dairy cows in early lactation
frequently suffer from their inability to consume sufficient
feed to support the amount of energy required for mainte-
nance and milk production, leading to negative energy bal-
ance (EBAL), which is reflected in the mobilisation of body
reserves. If this mobilisation is too extensive, this may create
physiological imbalances, which in turn make the animal
more susceptible to both metabolic and infectious diseases
(Ingvartsen, 2006). To date, most indicators of physiological
imbalance have been based on measurements of blood
metabolites (e.g. β-hydroxybutyrate (BHB), non-esterified
fatty acids (NEFAs), glucose and urea) and hormones
such as serum IGF-1 (Chagas et al., 2007; Wathes et al.,
2007; Ingvartsen and Moyes, 2013). Milk enzymes such as
N-acetyl-β-D-glucosaminidase (NAGase) and lactate dehy-
drogenase (LDH) also show potential as biomarkers to
describe udder health. Currently, tests for BHB in milk and
blood and blood glucose (Mair et al., 2016) and LDH can
be conducted cow-side.
New spectrophotometric techniques such as Fourier trans-
form mid-IR (FT-MIR) spectra of milk show promising per-
spectives to provide more timely information for improved
herd management in relation to metabolic health. Fourier
transform mid-IR can reliably predict the concentrations of
BHB, acetone and citrate (Grelet et al., 2016). It is highly
likely that other metabolites can also be predicted from
FT-MIR, and this would reduce the costs (and possibly time)
associated with more traditional biochemical methods and
provide the possibility to have more detailed time series of
observations. Such developments lead to the potential for
incorporating the monitoring of metabolic health into the
area of precision livestock farming (PLF). Berckmans
(2017) defined PLF as managing individual animals by con-
tinuous real-time monitoring of health, welfare and produc-
tion. In non-biological production systems, process control
charts are often used to monitor the production system; how-
ever, they have also been applied in animal production
(Mertens et al., 2011). One approach of what should be
monitored in process control is that it is not the outcome
of the production process that is monitored but a suitable
indicator of the production process that mirrors the current
state of the production system (Mertens et al., 2011). The
goal is to have a production process where the amount or
quality of the process outcome will be predictable using
the indicator. Despite a production process being predictable,
it does not necessarily mean that it is also acceptable.
Using this terminology with respect to the present paper,
process outcome refers to the occurrence of metabolic dis-
eases and indicators refer to the observations of the individ-
ual cows’ metabolic status measured by the biomarkers.
The production process is then predictable if the biomarkers
can predict the occurrence of metabolic diseases, but if not
predictable, assignable cause of process variation should be
eliminated. Process control charts were a natural predecessor
of PLF although to develop both, detailed information about
the normal variation in the control input is needed. Milk and
blood biomarkers have been analysed for decades in research
settings (Andersson, 1984; Jensen et al., 1993) and in some
commercial herds (Stengärde et al., 2010). Very often the
observations come from one research herd, making the esti-
mation of herd variance impossible. When multiple herds are
included, herd effects are often treated as uninteresting cova-
riates that are all too often removed to elucidate the research
question (e.g. Ospina et al., 2010; Seifi et al., 2011). If sub-
stantial between- and within-herd variation exists in blood
and milk biomarkers, this may result in poor predictions
of the process outcome. The four different levels of variation
(random, within-cow/temporal, cow-level and herd-level)
are described as follows: (1) Random variation, due to
measurement error induced by sampling or analytical error.
(2) The temporal within-cow variation in the biomarker:
this is due to diurnal variation (Nielsen et al., 2003) and
differences in sampling time relative to feeding. Both ran-
dom and within-cow variation should be minor compared to
the difference in means between the healthy and imbal-
anced population; otherwise, there will be substantial mis-
classification of the truly healthy v. truly imbalanced cows.
This could be accounted for by more observations from each
cow or by adjusting for diurnal patterns. (3) Variation in the
biomarker due to differences between cows: this source of
variation arises from cows responding differently to the
same metabolic challenge, even if they remain healthy.
Genetic differences between individual cows that result
in some metabolic pathways functioning more efficiently
than others could result in systematic differences in baseline
levels of the biomarkers. Such genetic differences in EBAL
have been found (Berry et al., 2007). Also, the cow’s physio-
logical constitution could provide systematic differences
in the biomarkers: for example, two cows with the same
challenge in terms of EBAL would most likely respond very
differently in blood/milk BHB depending on their body con-
dition. This is related to construct validity (O’Leary-Kelly and
Vokurka, 1998) where it should be carefully evaluated if the
observed biomarker actually measures what it is intended
to – here the metabolic challenge the cow is exposed to.
The importance of cow-to-cow variation within healthy or
imbalanced cows depends on the size of the variation, com-
pared to differences between balanced and imbalanced
cows. If cow-to-cow variations are large within healthy
cows, then biomarker observations that are normal for
one cow could be imbalanced for another, thus requiring
multiple observations on individual cows for PLF tools to
function. Additional observations of the individual cow will
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not improve this issue because repeated observations
within an individual cow will be correlated. (4) Variation
in individual cow biomarkers that can be attributed to
all cows in the herd: for example, feeding strategy will
clearly affect the metabolic status of cows in any herd,
and dependent on the diet, a small or large number of cows
may be imbalanced. Herd variation, however, means that
the same diet may result in specific patterns or levels of
biomarkers in different herds, dependent on other manage-
ment factors such as milking frequency, feed management,
stocking density, etc. Such management factors could, for
example, affect biomarkers by influencing the glucocorti-
coid levels (Huzzey et al., 2012) that influence energy
metabolism. Another explanation for herd variation could
be the presence of dominant genotypes within herds, so
it is actually an accumulated cow effect. The importance
of the herd variation in biomarkers is again dependent
on differences in the biomarkers between the imbalanced
and healthy population. The implication of this sort of
variation is that multiple observations within each herd
are needed to adjust the PLF tool to the herd-specific
threshold.
The objective of this study was to estimate the between-
and within-herd variation in key bloodmetabolites/hormones
(BHB, NEFA, glucose, urea, fructosamine, cholesterol and
IGF-1), milk metabolites/enzymes (BHB, glucose, urea, isoci-
trate, glucose-6-phosphate, uric acid, NAGase and LDH) and
composite indicators for metabolic imbalances (EBAL and
Physiological Imbalance-index (PI-index)), so as to assist
the implementation of these into PLF.
Material and methods
Animals, data storage and transportation of samples
A comprehensive set of samples and data were collected
between calving and 50 days post calving (1 to 50 days in
milk (DIM)) from 241 Holstein cows in 6 research herds:
35 from DK (Aarhus University, Denmark); 39 from IE
(UCD Lyons Research Farm, University College Dublin,
Ireland); 62 from UK (Agri-Food and Biosciences Institute,
Northern Ireland, UK); 31 from BE (Walloon Agricultural
Research Centre, Belgium); 29 from DE (Leibniz Institute
for Farm Animal Biology, Germany) and 45 from IT
(Consiglio per la Ricerca in Agricoltura, Italy). Seven cows
were culled before 50 DIM (1 UK, 3 DE and 3 IE) and were
subsequently excluded; thus, data from 234 cows were
available for analyses. Of these 234 cows, 55 were in parity
1, 66 were in parity 2 and 113 were in parity ≥3 (3þ), giving
an overall median lactation number of 2 (max lactation
number 7). All data were stored in a central repository at
Dairy Data Warehouse, The Netherlands. Data were checked
for errors, validity and agreement between original data and
data from the repository. Blood plasma, serum and milk sam-
ples were transported frozen between the place of collection
and the appropriate laboratory by commercial transport com-
panies. Samples were shipped in insulated containers in the
presence of dry ice. The consignments were in all instances
checked for residual dry ice at reception.
Diets and feed intake
Cows in two of the herds (UK and DK) were offered three con-
trasting diets, some of which were designed to challenge the
cows metabolically (the ‘High sugar’ diet should be ketogenic
and the ‘High starch’ should induce acidosis in DK), while
cows in the remaining four herds were offered diets which
reflected local management practices (Table 1). Automated
electronic feed intake recording systems were used to record
daily intakes of individual cows from DK/IE (Insentec,
Markneesse, the Netherlands) and UK (Calan gates linked
to an automatic cow identification system (American
Calan, Northwood, NH, USA), which allowed cows to gain
access to feed boxes mounted on weighing scales (Griffith
Elder, Bury St. Edmunds, UK)). In DE, the total mixed ration
was placed in troughs on scales, connected to a computer.
Feed intakes were not recorded in BE or IT.
Milk yield and composition
All cows were milked twice daily, and yields (volumes) were
recorded from approximately three DIM.Milk samples, contain-
ing Bronopol 0.02% as a preservative, were collected from con-
secutive morning and evening milkings twice weekly from
seven DIM onwards, stored at 4°C and subsequently analysed
by FT-MIR for composition of protein, fat and lactose. The
morning and evening compositions were weighted for milk
yields to provide a daily weighted average composition.
Live BW recording and health records
Live BWs of cows were recorded on at least two occasions
over the 7-week period from all herds except IT. The fre-
quency of weighing differed markedly between herds: DK
and UK at every milking (i.e. twice per day), IE and DE on
average 2 and 3 times per week and BE twice during the
study period (at approximately 14 and 35 DIM). Details of
health problems and their treatments for individual cows
were obtained from herd health records. The detection of
health problems and subsequent treatment followed the nor-
mal management practice in the herds. No attempts were
made to assess the agreement between diagnostic proce-
dures in different countries.
Blood sampling and analyses of metabolites and IGF-1
At approximately 14 DIM (mean= 14.1, SD= 2.0, range: 11
to 20) and 35 DIM (mean= 34.8, SD= 1.9, range: 31 to 38),
blood samples were collected by jugular venepuncture to
obtain plasma (in Na heparin tubes) and serum (plain tubes):
plasma and serum were separated by centrifugation and
stored at −20°C for subsequent analysis. Urea and choles-
terol were determined in plasma according to standard pro-
cedures using an auto-analyser, ADVIA 1800® Chemistry
System (Siemens Medical Solutions, Tarrytown, NY, USA).
Glucose, NEFA, BHB and fructosamine were determined
according to Bjerre-Harpoth et al. (2016). Intra- and inter-
assay CVs were in all cases below 3% and 4%, respectively,
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for both low and high control samples. Laboratory analyses
of all blood metabolites were carried out at the Department
of Animal Science, Aarhus University, Denmark. Concent-
rations of IGF-1 were determined in serum by radioimmuno-
assay at University College Dublin, Ireland, following
acid–ethanol extraction using the method as described by
Beltman et al. (2010). Intra-assay CVs were 12.4%, 7.5%
and 9.9% for low, medium and high control samples, respec-
tively. The corresponding inter-assay CVs were 7.8%, 3.9%
and 9.4%. The sensitivity of the assay, defined as the lowest
concentration detectable, was 4 ng/ml.
Milk sampling and analysis for metabolites and enzymes
Additional milk samples were collected twice weekly during
morningmilking, starting at around seven DIM. On each occa-
sion, two 8 ml samples were obtained and stored at−18°C in
tubes with stoppers. Fluorometric end point analyses were
used to determine milk glucose and glucose-6-phosphate
(Larsen, 2015), uric acid (Larsen and Moyes, 2010), isocitrate
(Larsen, 2014) and BHB (Larsen and Nielsen, 2005).
Urea was determined by spectrophotometry (Nielsen et al.,
2005). The indigenous enzymes LDH (EC. 1.1.1.27) and
NAGase (EC 3.2.1.30) were analysed by fluorometric assays
according to Larsen (2005) and Larsen et al. (2010). Intra-
and inter-assay CVs were in all cases below 5% and 8%,
respectively, for both low and high control samples. The analy-
sis of milk metabolites and enzymes was carried out at the
Department of Animal Science, Aarhus University, Denmark.
Derived measures
Feed samples collected weekly from UK, DK and IE were ana-
lysed for Net Energy for Lactation (NEL) in a single run at
Cumberland Valley Agricultural Services, Maryland. Energy
balance (inMJ/day), derived fromNEL, was determined accord-
ing to the National Research Council (NRC, 2001): EBAL= NEL
feed intake − NEL milk production − NEL maintenance. From
this, the energy input from daily DM intake (DMI) was calcu-
lated by multiplying the weekly NEL with the observed DMI.
Daily measures of milk yield were combined with the less fre-
quent analyses of fat, protein and lactose content using the
closest composition measure forwards in time to obtain the
NEL used for milk production. Energy balance was only calcu-
lated if both morning and evening yield were available for the
current day. Afterwards, three days (i.e. ±1 DIM) moving aver-
ages of EBAL were calculated and used for the analyses
(Supplementary Material Table S1). The average BW within
calendar week was used to smooth large day-to-day variation
and measurement errors of scales.
Physiological imbalance-index was calculated as
[log10(NEFA)]þ [log10(BHB)]− [glucose] (Moyes et al., 2013),
where plasma concentrations of the individual metabolites
were standardised to an overall mean of zero and variance
of one (as indicated by square brackets).
Statistical analysis
Statistical analyses and calculations were carried out using R
3.4.4 (R Core Team, 2018), and a 5% level of significance was
chosen. Descriptive statistics were calculated as mean, SD,
minimum, maximum and quartiles. Multilevel random
regression models, with the levels herd/diet and cows, were
used to estimate the variance components in the potential
milk and blood biomarkers adjusted for DIM and parity. In
the models for EBAL and milk metabolites and milk enzymes,
DIM was included as a quadratic term and all two-way
Table 1 Overview of the diets fed to the 234 Holstein dairy cows within the 6 experimental herds
Herd Ingredients Diet n cows
UK Three iso-nitrogenous diets comprising mixtures of grass silage and
concentrate in different ratios on a DM basis.
Low C: 30% 20
Standard C: 50% 20
High C: 70% 21
DK Three iso-nitrogenous and iso-calorific diets comprising grass silage,
maize silage, sugar beet pulp pellets, and concentrate including
high level of barley in the ‘High starch’ diet and high level of
dextrose in the ‘High sugar’ diet. The ‘High starch’ diet was
intended to induce acidosis, and the ‘High Sugar’ diet was
intended to induce ketosis.
High starch: 54% C 11
High sugar: 54% C 10
Standard: 49% C 14
IE A standard diet comprising grass silage, maize silage, sugar beet
pulp pellets and concentrate. In addition, each cow was offered
8 kg of concentrate per day in the parlour at milking.
Standard: 20% C 36
BE A standard diet changing over time to include summer grazing. The
standard diet comprised grass silage, maize silage and
concentrate. Moreover, cows were offered 1 kg concentrate per
2.5 l milk above 25 l/day with a maximum of 6 kg C/day at milking.
Standard: 17% C 31
DE A standard diet comprising grass silage, maize silage, and
concentrate.
Standard: 50% C 26
IT A standard diet comprising sorghum silage, alfalfa hay, meadow hay
and concentrate.




interactions were included. Similar models with DIM as a
2-level factor (DIM14 and DIM35) were used to estimate
the variance components in the potential blood biomarkers
and PI-index.
The intraclass correlation coefficient (ICC) was calculated
as the proportion of the total variance which could be attrib-
uted to a specific level (herd/diet or cow). For example,
ICCcow ¼ Varcow= Varherd=diet þ Varcow þ Residual
 
describes the proportion of the variance that can be attrib-
uted to cows that are adjusted for the covariates. Model
control was done by assessing qq-plots and plots of residuals
v. fitted values and residuals v. DIM for each herd/diet
combination and parity group.
Results
Production and health data
Summary statistics for daily milk yield for each of the herds
(and by diet in the case of UK and DK) are presented in
Table 2. Milk yield over the 7-week period averaged
33.3 ± 9.3 kg/day, increasing from 25.8 ± 8.1 kg/day in week
1 to 36.1 ± 9.3 kg/day in week 7. Of the 234 cows on the
study, 73 had a clinical diagnosis recorded (Table 3), with
mastitis, metritis, retained placenta and endometritis being
the predominant health issues. Eleven of the recorded diag-
noses could be associated directly with metabolic disease.
The production results and cow characteristics were
within the expected range for Holstein dairy cows in early
lactation (Table 2). Despite some of the diets being designed
to create metabolic challenges (e.g. Ketogenic ‘High Sugar’
diet in DK), the health records demonstrated that the cows
had a high metabolic health status (Table 3). The limited
number of clinical diseased cows would most likely only
be a minor contribution to the overall variation in the bio-
markers; however, there could be systematic differences in
detection and treatment thresholds in the different herds that
could have resulted in failure to observe some cases. This also
indicates that the vast majority of the observations of EBAL,
milk metabolites, milk enzymes and blood metabolites were
within the range of variation that could be expected from dif-
ferent herds with individual diets and management and other
assignable causes of variation. The observations from this
study can be used to estimate variance components related
to herd/diet, cows and within cows related to normal process
variation. However, the process variation will be overesti-
mated because the assignable causes (also diseases) have
not been removed.
Energy balance, milk metabolites and milk enzymes
Energy balance was calculated for the three herds (UK, DK
and IE) which had the necessary feed intake and ration
Table 3 Clinical diagnoses of Holstein dairy cows during the period
from calving to 50 DIM (73 cows had a clinical diagnosis, while 161
cows had no clinical diagnoses recorded)
ICAR term1 ICAR code Occurrence
Anoestria 2.05.02.01.02. 4
Bronchopneumonia 1.06.07.06. 8
Digital dermatitis 1.10.07.10. 1
Displaced abomasum 1.07.12.05. 6
Endometritis 2.05.01.01. 19
Interdigital hyperplasia 1.10.06.10. 4
Lameness 1.09.05. 9
Mastitis 1.13. 43
Metabolic diseases and deficiencies 6. 1
Metritis 2.04.05.02. 20
Milk fever 6.03.01.01. 4
Peritonitis 1.07.14.03. 3
Retained placenta 2.04.03. 20
Sole ulcer 1.10.07.03. 1
Total (n= 73 cows) 143
DIM= days-in-milk.
1ICAR terms sorted alphabetically.
Table 2 Summary statistics for daily milk yield (kg/day) of Holstein dairy cows over the study period (1 to 50 DIM)
Herd Diet Mean (SD) Median (Q1; Q3) Min; Max ncows nsamples
UK Low C 28.5 (7.4) 27.9 (22.8; 33.4) 14.0; 56.1 20 820
Standard C 32.6 (9.3) 33.1 (25.1; 39.6) 7.9; 57.0 20 859
High C 37.2 (10.3) 38.9 (29.2; 45.0) 7.7; 64.5 21 870
Pooled 32.8 (9.8) 32.6 (25.4; 40.2) 7.7; 64.5 61 2549
DK High starch 37.7 (10.7) 36.8 (28.9; 44.6) 13.0; 63.1 11 465
High sugar 35.4 (7.1) 36.4 (30.6; 40.3) 14.0; 51.3 10 452
Standard 39.7 (9.4) 39.5 (33.6; 47.2) 7.5; 61.8 14 609
Pooled 37.8 (9.4) 37.6 (31.5; 44.3) 7.5; 63.1 35 1526
IE Standard 33.0 (7.1) 33.3 (29.1; 37.9) 10.4; 52.4 36 1442
BE Standard 30.5 (8.6) 30.1 (24.6; 35.9) 7.0; 62.2 31 1324
DE Standard 38.6 (8.5) 39.6 (34.9; 44.4) 2.7; 62.3 25 1139
IT Standard 29.8 (8.0) 30.3 (24.1; 35.8) 3.3; 50.8 43 2089
All Pooled 33.3 (9.3) 33.6 (26.8; 39.5) 2.7; 64.5 231 10 069
DIM= days-in-milk; C= concentrate; Q1= first quartile; Q3= third quartile.
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composition data available (n= 132 cows). While there were
some missing values (weeks 1 and 7 in particular), the aver-
age coverage from 6 to 47 DIM was 82%. Average
EBAL within each herd/diet combination ranged from
−29.9MJ/day in the low concentrate diet in UK to 3.1MJ/day
in the high concentrate diet in UK (with all other diets in
between: SupplementaryMaterial Table S1) and a SDwithin diet
from 24.9 to 33.2 MJ/day. High concentrate and high starch
diets offered in UK and DK, respectively, increased EBAL.
Summary statistics of EBAL with respect to parity groups are
shown in Supplementary Material Table S2, and summary sta-
tistics in relation to DIM for the milk metabolites and enzymes
are shown in Supplementary Material Tables S3 and S4.
In Table 4, the variance components and ICCs from the
multilevel regression models of milk metabolites, milk
enzymes and the composite EBAL measure are shown, when
DIM and parity are accounted for. The ICC for herd/diet
ranged from 12% for glucose-6-phosphate and LDH to
46% for urea. The ICC for cow ranged from 17% for urea
to 48% for NAGase. The percentage of the total variance that
can be explained by herd/diet or cow effects (sum of
ICCherd/diet and ICCcow) ranged from 42% for isocitrate to
63% for urea, with the majority around 50%. The ratio
between herd/diet variance and cow variance ranged from
0.30 for LDH and NAGase to 2.55 for urea. A high ratio indi-
cates that herd/diet is a far more important source for varia-
tion than the individual cow. Supplementary Material Figures
S1 to S9 provide additional description and model control,
herd/diet and parity predictions, together with residuals v.
fitted values and residuals v. DIM for overall EBAL and each
of the individual milk biomarkers. The figures show the over-
all predicted trends in the milk biomarkers between DIM 1
and 50 and the average difference between herd/diet and
parity. The residual plots of residuals v. fitted values demon-
strate outliers in many of the biomarkers and issues related
to variance homogeneity between parity groups and
between different herd/diet combinations, and in some
plots, trends and funnel shapes were observed. The qq-plots
(not shown) showed some issues with the normality
assumptions especially for BHB, LDH and NAGase and that
log10-transformation did not entirely solve this.
Blood metabolites, IGF-1 and physiological imbalance-
index
Descriptive statistics of the blood metabolites, IGF-1 and PI-
index measured at approximately 14 and 35 DIM are pre-
sented in Supplementary Material Table S5. The variance
components and the ICCs related to herd/diet and cow are
given in Table 5.
The ICC for herd/diet ranged from 17% for cholesterol to
47% for urea, when DIM and parity were accounted for. The
ICC for cows ranged from 23% for urea to 54% for choles-
terol. The percentage of the total variance that could be
explained by herd/diet or cow effects (sum of ICCherd/diet
and ICCcow) ranged from 56% for NEFA to 75% for IGF-1,
with the majority around 60%. The ratio between herd/diet
variance and cow variance ranged from 0.31 for cholesterol
to 2.03 for urea. The models were checked by box plots of the
residuals on the two time points and plots of residual v. fitted
values, and no obvious deviations were found.
Comparing the ICCs from milk v. blood for urea, glucose
and BHB showed that the ICCs were roughly equal, except
for the herd/diet ICC for BHB (20% for milk v. 46% for blood).
Generally, clustering of the observations (correlation between
observations) within herds and cows is able to explain a larger
proportion of the total variance in blood than in milk.
Discussion
In this study, less than 5% of the cows developed metabolic
diseases across a range of very different feeding, housing and
management conditions. The disease incidence could be
underestimated because disease detection followed the nor-
mal management in the herds. However, these were research
herds and would generally be considered as well managed
and it is not unlikely that these cows are robust and are
not easily ‘pushed’ towards physiological imbalance by diet
Table 4 Variance components and ICC on EBAL and milk metabolites and enzymes from early lactation Holstein dairy cows
Model Herd/diet variance Cow variance Residual ICCherd/diet ICCcow
Herd/diet variance:
Cow variance
EBAL1 125 289 389 0.15 0.36 0.43
Uric Acid 611 687 1746 0.20 0.23 0.89
Urea 0.84 0.33 0.66 0.46 0.17 2.55
Isocitrate 0.0003 0.0005 0.0011 0.18 0.24 0.60
log10(BHB) 0.0096 0.0163 0.0221 0.20 0.34 0.59
Glucose 0.0024 0.0026 0.0033 0.29 0.31 0.92
Glucose-6-phospate 0.0005 0.0015 0.0020 0.12 0.37 0.33
log10(LDH) 0.0078 0.0263 0.0325 0.12 0.39 0.30
log10(NAGase) 0.0066 0.0220 0.0169 0.15 0.48 0.30
ICC= intra class correlations; EBAL= energy balance; BHB= β-hydroxybutyrate; LDH= lactate dehydrogenase; NAGase= N-acetyl-β-D-
glucosaminidase.
In the model variation that could be attributed to parity and lactation stage is removed.
1Energy Balance was calculated for three herds (UK, DK and IE) and seven diets.
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challenges. We now assume that the diseased cows only con-
tribute little to the variation in the biomarkers because of the
fairly low observed disease incidence. We could have chosen
to remove the diagnosed cows from the data/analysis, but we
prefer this more transparent approach of not reducing data
based on uncertain diagnostic criteria.
We estimated the variance components related to herd/
diet, cow and within-cow/random variation adjusted for parity
and DIM at sampling. These two adjustments reduced the
amount of variation at a cow-level (parity adjustment) and
within cows (DIM at sampling). Generally, the proportion of
the variation that could be associated with cow or herd/diet
was higher for the blood metabolites than milk metabolites
and milk enzymes, which may in part be due to the limitation
of having only two observations per cow in the study period for
the blood metabolites. The ICCs for herd/diet for plasma urea
and BHB were 0.47 and 0.46, respectively, indicating that
almost half of the variation in these observations should be
associated with herd/diet factors common to all cows in the
herd. For plasma urea and BHB, the ratios between herd/diet
variance and cow variance were 1.6 and 2.0 and the total pro-
portion of variance associated with either herd/diet or cowwas
70% and 74%, respectively. The other blood metabolites
showed proportions between herd/diet variance and cow vari-
ance around and below 1, which indicates that cow variation
was relatively more important. For urea, the results were as
expected because dietary protein intake influences blood urea
(Carroll et al., 1988) and there is substantial variation in blood
urea in relation to feeding (Gustafsson and Palmquist, 1993),
which would provide a distribution of the variation as found
here. The descriptive box plots of log10(BHB) in blood
(Supplementary Material Figure S10) highlight substantial
variation between herd/diet, but the distribution of the obser-
vations within herd/diet was almost identical at 14 and 35
DIM. A commonly applied threshold for BHB in blood is
1.2 mM (0.08 on log10-scale) for subclinical ketosis in both
practice and academia. There are cows that cross this thresh-
old in DK (High Sugar diet), BE and DE. Comparing these
results with the EBAL estimated from UK, DK and EI
(Supplementary Material Table S1) suggest that it is not only
EBAL that determines blood BHB concentrations, since there
are no high BHB levels in the herd/diet combination with the
highest negative EBAL, and none in the DK standard diet,
with the latter very similar in EBAL to the ‘High Sugar’ diet,
that were designed to be ketogenic. These results suggest
that fixed thresholds for BHB in blood can be problematic
to describe the metabolic status of a cow.
For metabolites and enzymes measured in milk, less of the
variation could be attributed to herd/diet or cow. Urea in milk
followed the same pattern as urea in blood, whereas for BHB,
the ICCherd/diet was reduced from 46% in blood to 20% in
milk. For milk BHB, the total amount of variation that could
be attributed to herd/diet or cowwas 54%. Because there are
diurnal fluctuations in blood BHB relative to feeding (Quiroz-
Rocha et al., 2010) and also within total mixed ration-
based systems (Nielsen et al., 2003), it could be hypothesised
that milk BHB provides a more robust indicator of the
metabolic challenges in the cow. In addition, the relatively
high ICCherd/diet for BHB in blood might be explained by
variation between blood sampling time points between
herds (morning v. afternoon).
Glucose in milk is not produced by the mammary epithelia
cells but is transported directly from the blood stream. However,
the mammary epithelia also utilise glycose for multiple meta-
bolic pathways, including conversion to lactose (Annison,
1983). Larsen andMoyes (2015) not only found large variations
in the glucose and glucose-6-phosphate inmilk but also stressed
that more work is needed to identify the mechanisms that can
relate these metabolites to disease risk. Residual analysis of the
relations between the same blood and milk metabolites could
be a useful approach to understand these relations in more
details including the variation related to herd/diet.
The LDH and NAGase are enzymes that are commonly used
as udder health indicators. In this study, we found ICCherd/diet of
12% and 15% for LDH and NAGase and the ratio between
herd/diet and cow variance was 0.3 for both. These results
are in line with the study of Åkerstedt et al. (2011), who also
suggested that the use of LDH as an indicator of mastitis
requires adjustment for the individual cow (and quarter).
The variance that is attributed to the herd/diet was the lowest
found in this study and is likely related to differences inmastitis
incidence between the different herds.
The results presented here describe biomarkers in early
lactation cows in a range of different environments,
Table 5 Variance components and ICC on PI-Index, IGF-1 and blood metabolites from early lactation Holstein dairy cows
Model Herd/diet variance Cow variance Residual ICCherd/diet ICCcow
Herd/diet variance:
Cow variance
PI-index 1.59 1.65 1.44 0.34 0.35 0.96
IGF-1 0.032 0.030 0.021 0.39 0.36 1.07
Urea 0.65 0.32 0.42 0.47 0.23 2.03
log10(BHB) 0.026 0.016 0.014 0.46 0.28 1.63
log10(NEFA) 0.019 0.032 0.042 0.21 0.35 0.59
Glucose 0.064 0.068 0.086 0.29 0.31 0.94
Fructosamine 94.4 101.4 134.0 0.29 0.31 0.93
Cholesterol 0.13 0.42 0.23 0.17 0.54 0.31
ICC= intra class correlations; PI-Index= physiological imbalance-index; BHB= β-hydroxybutyrate; NEFA= non-esterified fatty acid.
In the model variation that could be attributed to parity and lactation stage is removed.
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management and feeding strategies. The variance compo-
nents can then be considered an estimate of normal variation
in the biomarkers, when parity and DIM are accounted for.
However, as demonstrated by the Supplementary Material
Figures S1 to S9 accounting for herd/diet, parity and DIM
did not explain all the variation in the data, which indicates
that other (unobserved) sources of variations contribute to
the residual variation. The number of outliers, the differences
in residual variance between parity groups and diets and
trends in the residuals suggest that this is not only true ran-
dom error of the production process. We have shown that
herd and DIM contribute to the total variation in the bio-
markers, but the residual plots indicate that other sources
of variation exist as well. A potential source of variation could
be physiological imbalance, and these deviations could be con-
sidered predictors of disturbed production process. If these bio-
markers should be used for monitoring at an individual cow
level, these additional sources of variation should be identified
and removed, thereby reducing total variation and improving
the predictability of the biomarker. Other diseases could be
potential assignable causes of variation in the biomarkers.
Identification of sources of variation will be a continuous proc-
ess involving carefully scrutinising outliers and deviations in
variation in each of the biomarkers. Based on this study,
NAGase and LDH are not heavily influenced by herd factors
so these could be considered useful biomarker for mastitis
on cow level and useful for PLF. The other biomarkers, like
BHB, are influenced by herd factors which suggest that thresh-
olds should be set locally to describe the metabolic status of
the cows and further work is needed to do this. However in
general, the larger the difference in a biomarker between
healthy and the metabolically challenged populations, the
greater the amount of variation that can be accepted within
the healthy population. The variance components as depicted
here can be used to provide some guidelines into what should
be considered exceptional variation. Variations associated
with the cow and herd/diet level are of importance because
these cannot just be accounted for by additional recordings
of the individual. In addition, a common threshold for interven-
tion cannot be applied unless there is a large difference
between the healthy and imbalanced populations. Variations
in the biomarkers between the cows are most likely the most
problematic source of variation because this necessitates
multiple observations for each cow. Between-cow variation
is described for acetoacetate and BHB as ‘individual sensitivity
for hyperketonemia’ in the appearance of clinical signs of keto-
sis (Andersson, 1984). Herd/diet variations would be less of a
challenge because the PLF tool would only need to be adjusted
for each herd and/or diet. In addition, the variances in the
biomarkers presented here could be beneficial in simulation
studies to estimate potential impact of PLF with varying prev-
alences of metabolic disease.
Conclusions
The ICCs for the milk metabolites and blood metabolites dem-
onstrated that varying proportions of the variance could be
associated with herd/diet and individual cow. Intraclass corre-
lations related to the herd-diet combination were generally
higher for blood metabolites than milk metabolites. These
results provide valuable information about the variation in a
range of biomarkers, which can be used for subsequent
simulations to assess the potential of the biomarkers in PLF.
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